Post by peppy on Jan 6, 2016 9:06:14 GMT -5
(well, sabotage )
More importantly, take Canada, a national health care system and Europe the same.
At the USA price points, USA insurance companies would not cover, these regional partnerships would be just as moot.
The Reason Price.
10 dollar or 3 dollars and we can tell them it's the same chit.
Peppy,
I'm not sure I understand your points.
1. What would the problem be with having an Eisai or a Takeda market the product in the Far East, for example? Why moot?
2. Sabotage?
3. Price would obviously be lower elsewhere, just as the price has to be lowered in the U.S.
Thank you for your post, I miss understood. I was looking at other countries approval rather than the partnerships you were taking about.
I am sorry for the poor post, in this regard.